West Pharmaceutical Services | WST - Operating Expenses



West Pharmaceutical Services reported $612.8M in Operating Expenses for its fiscal quarter ending in June of 2025.


Operating Expenses Change Date
Align Technology USD 849.42M 1.25M Jun/2025
Avanos Medical USD 228.66M 71.46M Jun/2025
Baxter International USD 2.54B 29M Jun/2025
Becton, Dickinson and Co. USD 4.53B 196M Jun/2025
Charles River Laboratories USD 899.8M 9.7M Jun/2025
Cooper Companies USD 884.6M 67.1M Jul/2025
Dentsply International USD 825M 9M Jun/2025
Haemonetics USD 250.55M 29.34M Jun/2025
ICU Medical USD 522.06M 53.06M Jun/2025
Insulet USD 528M 8.3M Jun/2025
Integra LifeSciences USD 416.91M 18.3M Jun/2025
IQVIA Holdings USD 3.46B 124M Jun/2025
J&J USD 16.8B 8.54B Jun/2025
Medtronic USD 7.06B 430M Jul/2025
Merit Medical Systems USD 335.44M 21.12M Jun/2025
Neogen USD 238.71M 23.15M May/2025
Quidel USD 615.7M 28.4M Jun/2025
Repligen USD 176.41M 13.82M Jun/2025
Solventum Corp 1.95B 29M Jun/2025
STAAR Surgical USD 69.04M 8.29M Jun/2025
Terumo JPY 204.08B 35.68B Jun/2025
West Pharmaceutical Services USD 612.8M 21.8M Jun/2025